To examine the effect of SPOP mutations on ATF2 protein levels in specimens from individuals with prostate cancer, we analyzed ATF2 protein levels in a cohort for which a total of 90 primary prostate tumor samples were available (Additional file 1: Table S2). The gene discussed is SPOP; the disease is prostate neoplasm.